TRANSCODE THERAPEUTICS INC. - 1H - Technical analysis published on 05/10/2024 (GMT)
- 137
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Additional analysis
Quotes
TRANSCODE THERAPEUTICS INC. rating 1.55 USD. The price has increased by +16.54% since the last closing and was traded between 1.35 USD and 1.58 USD over the period. The price is currently at +14.81% from its lowest and -1.90% from its highest.The Central Gaps scanner detects a bullish opening marking the presence of buyers ahead of sellers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
The Central Volumes scanner notes the presence of abnormal volumes:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of this 1H chart of TRANSCODE THERAPEUTICS INC. indicates that the overall trend is strongly bullish. 92.86% of the signals given by moving averages are bullish. This strongly bullish trend is supported by the strong bullish signals given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
Technical indicators are strongly bullish, suggesting that the price increase should continue.
But beware of excesses. The Central Indicators scanner currently detects this:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : 1 hour
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : 1 hour
CCI indicator: bearish divergence
Type : Bearish
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 1 hour
The analysis of the price chart with Central Patterns scanners does not return any result.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 0.60 | 1.05 | 1.20 | 1.55 | 12.41 | 69.60 | 102.00 |
Change (%) | -60.99% | -32.26% | -22.58% | - | +700.67% | +4,390.32% | +6,480.65% |
Change | -0.95 | -0.50 | -0.35 | - | +10.86 | +68.05 | +100.45 |
Level | Major | Minor | Intermediate | - | Minor | Minor | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.67 | 0.82 | 1.08 | 1.23 | 1.49 | 1.64 | 1.90 |
Camarilla | 1.22 | 1.26 | 1.29 | 1.33 | 1.37 | 1.41 | 1.44 |
Woodie | 0.72 | 0.85 | 1.13 | 1.26 | 1.54 | 1.67 | 1.95 |
Fibonacci | 0.82 | 0.98 | 1.08 | 1.23 | 1.39 | 1.49 | 1.64 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.03 | 0.28 | 0.55 | 0.80 | 1.07 | 1.32 | 1.59 |
Camarilla | 0.68 | 0.73 | 0.77 | 0.82 | 0.87 | 0.92 | 0.96 |
Woodie | 0.04 | 0.29 | 0.56 | 0.81 | 1.08 | 1.33 | 1.60 |
Fibonacci | 0.28 | 0.48 | 0.60 | 0.80 | 1.00 | 1.12 | 1.32 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.16 | 0.29 | 0.45 | 0.58 | 0.74 | 0.87 | 1.03 |
Camarilla | 0.53 | 0.56 | 0.58 | 0.61 | 0.64 | 0.66 | 0.69 |
Woodie | 0.18 | 0.30 | 0.47 | 0.59 | 0.76 | 0.88 | 1.05 |
Fibonacci | 0.29 | 0.40 | 0.47 | 0.58 | 0.69 | 0.76 | 0.87 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 74.50 | |
MACD (12,26,9): | 0.1100 | |
Directional Movement: | 26.91 | |
AROON (14): | 85.72 | |
DEMA (21): | 1.24 | |
Parabolic SAR (0,02-0,02-0,2): | 1.04 | |
Elder Ray (13): | 0.16 | |
Super Trend (3,10): | 1.04 | |
Zig ZAG (10): | 1.33 | |
VORTEX (21): | 1.2000 | |
Stochastique (14,3,5): | 88.69 | |
TEMA (21): | 1.27 | |
Williams %R (14): | -12.77 | |
Chande Momentum Oscillator (20): | 0.31 | |
Repulse (5,40,3): | 10.6300 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 1.4400 | |
Courbe Coppock: | 34.06 |
MA7: | 0.93 | |
MA20: | 0.66 | |
MA50: | 0.67 | |
MA100: | 1.80 | |
MAexp7: | 1.23 | |
MAexp20: | 1.10 | |
MAexp50: | 0.93 | |
MAexp100: | 0.79 | |
Price / MA7: | +66.67% | |
Price / MA20: | +134.85% | |
Price / MA50: | +131.34% | |
Price / MA100: | -13.89% | |
Price / MAexp7: | +26.02% | |
Price / MAexp20: | +40.91% | |
Price / MAexp50: | +66.67% | |
Price / MAexp100: | +96.20% |
News
The last news published on TRANSCODE THERAPEUTICS INC. at the time of the generation of this analysis was as follows:
- TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
- TransCode Therapeutics Reports 2023 Results; Provides Business Update
- TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
- TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
- TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
Add a comment
Comments
0 comments on the analysis TRANSCODE THERAPEUTICS INC. - 1H